QQ客服 官方微博 反馈留言

	The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)
	Gao, Zhiliang; Zhu, Xiang; Lin, Bingliang; Yi, Jianhua; Gao, Wenjun; Chen, Youming; Xie, Dongying; Deng, Hong; Lin, Chaoshuang; You, Jing
刊名	HEPATOLOGY
	2018
卷号	68
ISSN号	0270-9139
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3414412
专题	昆明医科大学
推荐引用方式 GB/T 7714	Gao, Zhiliang,Zhu, Xiang,Lin, Bingliang,et al. The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)[J]. HEPATOLOGY,2018,68.
APA	Gao, Zhiliang.,Zhu, Xiang.,Lin, Bingliang.,Yi, Jianhua.,Gao, Wenjun.,...&Zhao, Qiyi.(2018).The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study).HEPATOLOGY,68.
MLA	Gao, Zhiliang,et al."The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)".HEPATOLOGY 68(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。